Table 2 Correlation analysis.
Protection study | Expt 1 (24 h) | Expt 1 (48 h) | Expt 2 (24 h) |
|---|---|---|---|
ELISA (FL-CSP) | 0.27 (0.30) | 0.75 (0.00) | 0.26 (0.28) |
ELISA (NANPx6) | − 0.54 (0.14) | − 0.73 (0.01) | − 0.14 (0.58) |
ELISA (SPZ) | − 0.47 (0.21) | − 0.60 (0.08) | 0.46 (0.02) |
ILSDA (0.5 µg/ml) | 0.54 (0.00) | 0.41 (0.11) | 0.71 (0.01) |
Avidity Index FL-CSP | 0.72 (0.01) | 0.68 (0.01) | 0.59 (0.03) |
Avidity Index NANPx6 | 0.68 (0.02) | 0.78 (0.00) | 0.67 (0.02) |
Avidity (FL-CSP) | 0.77 (0.00) | 0.53 (0.12) | 0.84 (0.00) |
Avidity (NANPx6) | 0.67 (0.03) | 0.77 (0.00) | 0.65 (0.02) |
KD Bivalent (FL-CSP) | − 0.55 (0.18) | − 0.80 (0.01) | − 0.26 (0.46) |
KD Fab (FL-CSP) | − 0.56 (0.25) | − 0.82 (0.05) | − 0.14 (0.86) |
KD Fab (NANP6) | − 0.56 (0.25) | − 0.73 (0.10) | − 0.34 (0.66) |
BSA (NPNA)n | 0.84 (0.04) | 0.81 (0.05) | 0.36 (0.64) |
BSA junctional | 0.65 (0.17) | 0.59 (0.22) | 0.20 (0.80) |